Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

NCT06394232 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Disease
Macular Degeneration
Age-Related Macular Degeneration
Geographic Atrophy
Eye Diseases

Interventions

DRUG: Eyecyte-RPE™

Sponsor

Eyestem Research Pvt. Ltd.